ÂÜÀòÂÒÂ×

Ian Eliason is a partner and co-founder at Zoic Capital, an IP centric life sciences venture fund. Ian is also a board member, investor, and advisor at ODS Medical Inc. Additionally, Ian is an investor and advisor at ChromaTan, Probius, BioROSA Technologies, HDT Bio, Optina Diagnostics, Innovein, and Juno Diagnostics. Ian holds a Bachelor of Science in Public Health, Finance, and Communications from the University of Minnesota.